GHP Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.8K | Sell |
32
-5
| -14% | -$2.63K | ﹤0.01% | 656 |
|
2025
Q1 | $23.5K | Buy |
37
+3
| +9% | +$1.9K | ﹤0.01% | 582 |
|
2024
Q4 | $24.2K | Buy |
34
+14
| +70% | +$9.97K | ﹤0.01% | 576 |
|
2024
Q3 | $21K | Hold |
20
| – | – | ﹤0.01% | 613 |
|
2024
Q2 | $21K | Hold |
20
| – | – | ﹤0.01% | 586 |
|
2024
Q1 | $19.3K | Hold |
20
| – | – | ﹤0.01% | 591 |
|
2023
Q4 | $17.6K | Hold |
20
| – | – | ﹤0.01% | 592 |
|
2023
Q3 | $16.8K | Hold |
20
| – | – | ﹤0.01% | 624 |
|
2023
Q2 | $16.1K | Hold |
20
| – | – | ﹤0.01% | 615 |
|
2023
Q1 | $16.4K | Sell |
20
-6
| -23% | -$4.93K | ﹤0.01% | 608 |
|
2022
Q4 | $18.8K | Hold |
26
| – | – | ﹤0.01% | 596 |
|
2022
Q3 | $18K | Buy |
26
+6
| +30% | +$4.15K | ﹤0.01% | 592 |
|
2022
Q2 | $12K | Hold |
20
| – | – | ﹤0.01% | 652 |
|
2022
Q1 | $14K | Buy |
+20
| New | +$14K | ﹤0.01% | 664 |
|